Back to state act
Back to state act
Description
On 7 June 2021, the U.S. Administration announced that the government will procure 1.7 million courses of Merck’s investigational antiviral treatment, molnupiravir (MK-4482) for USD 1.2 billion should...
Intervention Details
Intervention Type
Public procurement, nes
MAST Chapter
M: Government procurement restrictions
Implementation date
07 Jun 2021
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Sectors
Affected Products
See all
This intervention is not part of any Thread yet.